nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Abnormalities in uremic lipoprotein metabolism and its impact on cardiovascular disease
|
Quaschning, Thomas |
|
2001 |
|
4S |
p. S14-S19 6 p. |
artikel |
2 |
Abstracts From the Workshop on the Biology of Kidney Disease and Hypertension in Blacks
|
|
|
1993 |
|
4S |
p. 75-78 4 p. |
artikel |
3 |
A clinical trial in type 2 diabetic nephropathy
|
Lewis, Edmund J |
|
2001 |
|
4S |
p. S191-S194 4 p. |
artikel |
4 |
Activation of protein kinase C-δ and C-ϵ by oxidative stress in early diabetic rat kidney
|
Ha, Hunjoo |
|
2001 |
|
4S |
p. S204-S207 4 p. |
artikel |
5 |
Advanced glycation end products and the progressive course of renal disease
|
Heidland, August |
|
2001 |
|
4S |
p. S100-S106 7 p. |
artikel |
6 |
Association of endothelial dysfunction with sulfur amino acid metabolism in chronic renal failure
|
Takamitsu, Yoshihiro |
|
2001 |
|
4S |
p. S95-S99 5 p. |
artikel |
7 |
Association of transforming growth factor-β1 T29C polymorphism with the progression of diabetic nephropathy
|
Akai, Yasuhiro |
|
2001 |
|
4S |
p. S182-S185 4 p. |
artikel |
8 |
Atherogenic lipoproteins in end-stage renal disease
|
Shoji, Tetsuo |
|
2001 |
|
4S |
p. S30-S33 4 p. |
artikel |
9 |
Autonomic dysfunction in uremia
|
Savica, Vincenzo |
|
2001 |
|
4S |
p. S118-S121 4 p. |
artikel |
10 |
Basic Science Committee Recommendations
|
|
|
1993 |
|
4S |
p. 82-83 2 p. |
artikel |
11 |
Beneficial effects of adopting an aggressive intravenous iron policy in a hemodialysis unit
|
Macdougall, Iain C |
|
1999 |
|
4S |
p. s40-s46 nvt p. |
artikel |
12 |
Cardiovascular disease and chronic renal disease: A new paradigm
|
Sarnak, Mark J. |
|
2000 |
|
4S |
p. S117-S131 15 p. |
artikel |
13 |
Cardiovascular disease in end-stage renal disease patients
|
Collins, Allan J. |
|
2001 |
|
4S |
p. S26-S29 4 p. |
artikel |
14 |
Carnitine metabolism in uremia
|
Guarnieri, Gianfranco |
|
2001 |
|
4S |
p. S63-S67 5 p. |
artikel |
15 |
Cellular mechanisms in the development and progression of diabetic nephropathy: Activation of the DAG-PKC-ERK pathway
|
Haneda, Masakazu |
|
2001 |
|
4S |
p. S178-S181 4 p. |
artikel |
16 |
Central nervous dysfunction in uremia
|
Smogorzewski, Miroslaw J |
|
2001 |
|
4S |
p. S122-S128 7 p. |
artikel |
17 |
Changes in body fat mass in male hemodialysis patients: A comparison between diabetics and nondiabetics
|
Okuno, Senji |
|
2001 |
|
4S |
p. S208-S211 4 p. |
artikel |
18 |
Clinical effects of maxacalcitol on secondary hyperparathyroidism of uremic patients
|
Akizawa, Tadao |
|
2001 |
|
4S |
p. S147-S151 5 p. |
artikel |
19 |
Clinical Research Subcommittee Recommendations
|
|
|
1993 |
|
4S |
p. 85-87 3 p. |
artikel |
20 |
Comparison of intact PTH assay and whole PTH assay in long-term dialysis patients
|
Nakanishi, Shohei |
|
2001 |
|
4S |
p. S172-S174 3 p. |
artikel |
21 |
Conference participants
|
|
|
1999 |
|
4S |
p. s4- 1 p. |
artikel |
22 |
Depressed cerebral oxygen metabolism in patients with chronic renal failure: A positron emission tomography study
|
Kanai, Hidetoshi |
|
2001 |
|
4S |
p. S129-S133 5 p. |
artikel |
23 |
Editorial board
|
|
|
2001 |
|
4S |
p. A1- 1 p. |
artikel |
24 |
Effect of chronic renal failure on nitric oxide metabolism
|
Vaziri, N.D |
|
2001 |
|
4S |
p. S74-S79 6 p. |
artikel |
25 |
Effect of erythropoietin on cardiovascular diseases
|
Sunder-Plassmann, Gere |
|
2001 |
|
4S |
p. S20-S25 6 p. |
artikel |
26 |
Efficient and ligand-dependent regulated erythropoietin production by naked DNA injection and in vivo electroporation
|
Terada, Yoshio |
|
2001 |
|
4S |
p. S50-S53 4 p. |
artikel |
27 |
Epidemiologic Analysis of Existing Data to Investigate Hypertensive Renal Disease: An Example From the Maryland End-Stage Renal Disease Registry
|
Brancati, Frederick L. |
|
1993 |
|
4S |
p. 15-24 10 p. |
artikel |
28 |
Epidemiology Subcommittee Recommendations
|
|
|
1993 |
|
4S |
p. 79-81 3 p. |
artikel |
29 |
Erectile dysfunction in uremic dialysis patients: Diagnostic evaluation in the sildenafil era
|
Bellinghieri, Guido |
|
2001 |
|
4S |
p. S115-S117 3 p. |
artikel |
30 |
Essential Hypertension in Blacks: Is It a Metabolic Disorder?
|
Weir, Matthew R. |
|
1993 |
|
4S |
p. 58-67 10 p. |
artikel |
31 |
Ethnic Differences in Cellular Ions and Transport
|
Douglas, Janice G. |
|
1993 |
|
4S |
p. 46-52 7 p. |
artikel |
32 |
Ethnicity and Renal Disease: Lessons From the Multiple Risk Factor Intervention Trial and the Treatment of Mild Hypertension Study
|
Flack, John M. |
|
1993 |
|
4S |
p. 31-40 10 p. |
artikel |
33 |
Faculty
|
|
|
1999 |
|
4S |
p. s3- 1 p. |
artikel |
34 |
Future developments in the treatment of end-stage renal disease: A North American perspective
|
Henderson, Lee W. |
|
2000 |
|
4S |
p. S106-S116 11 p. |
artikel |
35 |
Genetic aspects of secondary hyperparathyroidism in uremia
|
Drüeke, Tilman B |
|
2001 |
|
4S |
p. S143-S146 4 p. |
artikel |
36 |
Genetics of kidney disease
|
George Jr, Alfred L. |
|
2000 |
|
4S |
p. S160-S169 10 p. |
artikel |
37 |
Genetics Research Subcommittee Recommendations
|
|
|
1993 |
|
4S |
p. 84- 1 p. |
artikel |
38 |
Hemodialysis in diabetic patients
|
Akmal, Mohammad |
|
2001 |
|
4S |
p. S195-S199 5 p. |
artikel |
39 |
History of the National Kidney Foundation
|
Brown, Wendy Weinstock |
|
2000 |
|
4S |
p. S3-S18 16 p. |
artikel |
40 |
History of the National Kidney Foundation's research efforts
|
Andreoli, Sharon P. |
|
2000 |
|
4S |
p. S31-S36 6 p. |
artikel |
41 |
History of the professional councils of the National Kidney Foundation
|
Atkins, Carolyn |
|
2000 |
|
4S |
p. S19-S30 12 p. |
artikel |
42 |
How end-stage renal disease (ESRD)-Medicare developed
|
Schreiner, George E. |
|
2000 |
|
4S |
p. S37-S44 8 p. |
artikel |
43 |
Hyperfiltration and Conservation of Renal Function in Hypertensive Nephrosclerosis Patients
|
Lee, Hing-Chung |
|
1993 |
|
4S |
p. 68-74 7 p. |
artikel |
44 |
Hypertensive End-Stage Renal Disease in Blacks: The Role of End-Stage Renal Disease Surveillance
|
McClellan, William |
|
1993 |
|
4S |
p. 25-30 6 p. |
artikel |
45 |
Impaired secretion of parathyroid hormone is coherent to diabetic hemodialyzed patients
|
Inaba, Masaaki |
|
2001 |
|
4S |
p. S139-S142 4 p. |
artikel |
46 |
Increased Fas antigen in uremia accelerates adhesion of mononuclear cells to endothelial and sinovial cells via stimulated hyaluronan production
|
Matsumoto, Junko |
|
2001 |
|
4S |
p. S54-S57 4 p. |
artikel |
47 |
Insulin secretion in uremia
|
Massry, Shaul G |
|
2001 |
|
4S |
p. S58-S62 5 p. |
artikel |
48 |
Introduction
|
Nishizawa, Yoshiki |
|
2001 |
|
4S |
p. S1- 1 p. |
artikel |
49 |
Introduction
|
Owen Jr, William F |
|
1999 |
|
4S |
p. s1-s2 nvt p. |
artikel |
50 |
Introduction: National Kidney Foundation 50th anniversary commemorative issue
|
Kopple, Joel D. |
|
2000 |
|
4S |
p. S1-S2 2 p. |
artikel |
51 |
Iron and cardiac disease in the end-stage renal disease setting
|
Besarab, Anatole |
|
1999 |
|
4S |
p. s18-s24 nvt p. |
artikel |
52 |
Iron and infection: Clinical experience
|
Hoen, Bruno |
|
1999 |
|
4S |
p. s30-s34 nvt p. |
artikel |
53 |
Iron status as measured by serum ferritin: The marker and its limitations
|
Cavill, Ivor |
|
1999 |
|
4S |
p. s12-s17 nvt p. |
artikel |
54 |
Kidney Disease and Hypertension in Blacks: Scope of the Problem
|
Jones, Camille A. |
|
1993 |
|
4S |
p. 6-9 4 p. |
artikel |
55 |
Localization of imidazolone in the peritoneum of CAPD patients: A factor for a loss of ultrafiltration
|
Nakamura, Sakurako |
|
2001 |
|
4S |
p. S107-S110 4 p. |
artikel |
56 |
1971 Medicare amendment: Reflections on the passage of the end-stage renal disease Medicare program
|
Plante, Charles L. |
|
2000 |
|
4S |
p. S45-S48 4 p. |
artikel |
57 |
Metabolic consequences of hyperhomocysteinemia in uremia
|
Perna, Alessandra F |
|
2001 |
|
4S |
p. S85-S90 6 p. |
artikel |
58 |
Mönckeberg's medial sclerosis and inorganic phosphate in uremia
|
Shioi, Atsushi |
|
2001 |
|
4S |
p. S47-S49 3 p. |
artikel |
59 |
More than 1,000 cases of total parathyroidectomy with forearm autograft for renal hyperparathyroidism
|
Tominaga, Yoshihiro |
|
2001 |
|
4S |
p. S168-S171 4 p. |
artikel |
60 |
National perspective on iron therapy as a clinical performance measure for maintenance hemodialysis patients
|
Owen Jr, William F |
|
1999 |
|
4S |
p. s5-s11 nvt p. |
artikel |
61 |
Nephrology in the 21st century: Revolutionary changes
|
Glassock, Richard J. |
|
2000 |
|
4S |
p. S90-S92 3 p. |
artikel |
62 |
New dialysis membrane for removal of middle molecule uremic toxins
|
Yamashita, Akihiro C |
|
2001 |
|
4S |
p. S217-S219 3 p. |
artikel |
63 |
Osteoclastogenesis and osteoclast activation in dialysis-related amyloid osteopathy
|
Kazama, J.James |
|
2001 |
|
4S |
p. S156-S160 5 p. |
artikel |
64 |
Osteoprotegerin levels before and after renal transplantation
|
Sato, Tetsuhiko |
|
2001 |
|
4S |
p. S175-S177 3 p. |
artikel |
65 |
Outcomes of hemodiafiltration based on Japanese dialysis patient registry
|
Nakai, Shigeru |
|
2001 |
|
4S |
p. S212-S216 5 p. |
artikel |
66 |
Outcomes of renal replacement therapy among blacks and women
|
Sehgal, Ashwini R. |
|
2000 |
|
4S |
p. S148-S152 5 p. |
artikel |
67 |
Paradox of risk factors for cardiovascular mortality in uremia: Is a higher cholesterol level better for atherosclerosis in uremia?
|
Nishizawa, Yoshiki |
|
2001 |
|
4S |
p. S4-S7 4 p. |
artikel |
68 |
Pathobiology of the role of iron in infection
|
Sunder-Plassmann, Gere |
|
1999 |
|
4S |
p. s25-s29 nvt p. |
artikel |
69 |
Peritoneal dialysis in diabetic patients
|
Lee, Hi Bahl |
|
2001 |
|
4S |
p. S200-S203 4 p. |
artikel |
70 |
Platelet aggregation and prostaglandin metabolism in uremic patients
|
Pietrzak, Irena |
|
2001 |
|
4S |
p. S111-S114 4 p. |
artikel |
71 |
Programmed filtration, a new method for removing large molecules and regulating albumin leakage during hemodiafiltration treatment
|
Kim, Sung-Teh |
|
2001 |
|
4S |
p. S220-S223 4 p. |
artikel |
72 |
Proteinuria and cardiovascular disease
|
Brown, Wendy Weinstock |
|
2001 |
|
4S |
p. S8-S13 6 p. |
artikel |
73 |
Proteinuria: Its clinical importance and role in progressive renal disease
|
Keane, William F. |
|
2000 |
|
4S |
p. S97-S105 9 p. |
artikel |
74 |
Psychosocial factors in adult end-stage renal disease patients treated with hemodialysis: Correlates and outcomes
|
Kimmel, Paul L. |
|
2000 |
|
4S |
p. S132-S140 9 p. |
artikel |
75 |
Putative parathyroid tumor suppressor on 1p: Independent molecular mechanisms of tumorigenesis from 11q allelic loss
|
Imanishi, Yasuo |
|
2001 |
|
4S |
p. S165-S167 3 p. |
artikel |
76 |
Racial Differences in Renal Sodium Excretion: Relationship to Hypertension
|
Weinberger, Myron H. |
|
1993 |
|
4S |
p. 41-45 5 p. |
artikel |
77 |
Renal insufficiency accelerates atherosclerosis in patients with type 2 diabetes mellitus
|
Ishimura, Eiji |
|
2001 |
|
4S |
p. S186-S190 5 p. |
artikel |
78 |
Renal rehabilitation: Obstacles, progress, and prospects for the future
|
Oberley, Edith T. |
|
2000 |
|
4S |
p. S141-S147 7 p. |
artikel |
79 |
Restructuring the National Kidney Foundation
|
Brand, Joseph L. |
|
2000 |
|
4S |
p. S81-S89 9 p. |
artikel |
80 |
Review of issues relating to iron and infection
|
Fishbane, Steven |
|
1999 |
|
4S |
p. s47-s52 nvt p. |
artikel |
81 |
Role of advanced glycation end products in adynamic bone disease in patients with diabetic nephropathy
|
Yamamoto, Takehisa |
|
2001 |
|
4S |
p. S161-S164 4 p. |
artikel |
82 |
Role of connective tissue growth factor in profibrotic action of transforming growth factor-β: A potential target for preventing renal fibrosis
|
Yokoi, Hideki |
|
2001 |
|
4S |
p. S134-S138 5 p. |
artikel |
83 |
Second International Congress on Uremia Research April 26-28, 2001 Nara-Ken New Public Hall (Shin-Kokaido) Nara, Japan
|
|
|
2001 |
|
4S |
p. S2-S3 2 p. |
artikel |
84 |
Skeletal resistance to PTH as a basic abnormality underlying uremic bone diseases
|
Fukagawa, Masafumi |
|
2001 |
|
4S |
p. S152-S155 4 p. |
artikel |
85 |
Structure and Regulated Expression of Angiotensin-Converting Enzyme and the Receptor for Angiotensin II
|
Bernstein, Kenneth E. |
|
1993 |
|
4S |
p. 53-57 5 p. |
artikel |
86 |
The Bioanthropological Context of Disease
|
Jackson, Fatimah Linda Collier |
|
1993 |
|
4S |
p. 10-14 5 p. |
artikel |
87 |
The dialysis outcomes quality initiative: History, impact, and prospects
|
Eknoyan, Garabed |
|
2000 |
|
4S |
p. S69-S75 7 p. |
artikel |
88 |
The Division of Kidney, Urologic, and Hematologic Diseases: Initiative for Research on Kidney Diseases and Hypertension in Blacks
|
Kusek, John W. |
|
1993 |
|
4S |
p. 1-2 2 p. |
artikel |
89 |
The Health of African Americans: Special Emphasis on Kidney Disease
|
Mason, James O. |
|
1993 |
|
4S |
p. 3-5 3 p. |
artikel |
90 |
The heart in uremia: Role of hypertension, hypotension, and sleep apnea
|
De Santo, Natale Gaspare |
|
2001 |
|
4S |
p. S38-S46 9 p. |
artikel |
91 |
The modern National Kidney Foundation: Broad scope, clear vision, better lives
|
Davis, John |
|
2000 |
|
4S |
p. S76-S80 5 p. |
artikel |
92 |
The National Kidney Foundation K/DOQI clinical practice guidelines for dietary protein intake for chronic dialysis patients
|
Kopple, Joel D. |
|
2001 |
|
4S |
p. S68-S73 6 p. |
artikel |
93 |
The partnership with affiliates: Our stories
|
Wyckoff, Suzanne J. |
|
2000 |
|
4S |
p. S49-S68 20 p. |
artikel |
94 |
The scientific and professional challenges for the National Kidney Foundation in the 21st century
|
Kopple, Joel D. |
|
2000 |
|
4S |
p. S93-S96 4 p. |
artikel |
95 |
The systemic inflammatory response and its impact on iron nutriture in end-stage renal disease
|
Bistrian, Bruce R |
|
1999 |
|
4S |
p. s35-s39 nvt p. |
artikel |
96 |
Thyroid function in patients with chronic renal failure
|
Lim, Victoria S |
|
2001 |
|
4S |
p. S80-S84 5 p. |
artikel |
97 |
Transplantation
|
Gonwa, Thomas A. |
|
2000 |
|
4S |
p. S153-S159 7 p. |
artikel |
98 |
Treatment of hyperhomocysteinemia in end-stage renal disease
|
Shemin, Douglas |
|
2001 |
|
4S |
p. S91-S94 4 p. |
artikel |
99 |
Vascular calcification and inorganic phosphate
|
Giachelli, Cecilia M |
|
2001 |
|
4S |
p. S34-S37 4 p. |
artikel |